CG Oncology (CGON) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 4, 2026, to be held virtually for shareholder participation.

• Proxy materials, including the Notice of Meeting, Proxy Statement, and Annual Report, are available online, with paper copies available upon request by May 25, 2026.

Voting matters and shareholder proposals

• Election of two Class II director nominees, Christina Rossi and Victor Tong, Jr., to serve until the 2029 Annual Meeting.

• Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Advisory vote to approve compensation of Named Executive Officers.

• Advisory vote on the preferred frequency (every 1 year) of stockholder advisory votes on executive compensation.

Board of directors and corporate governance

• Board recommends voting for all director nominees and for all proposals, including annual say-on-pay frequency.